Need Support?
Panel Miscoding
LCD Non-Compliance
Missed Reflex Testing Revenue
Frequency Limitation Violations
Wrong Methodology-Based CPT Codes
Comprehensive metabolic panel (CMP, 80053), basic metabolic panel (BMP, 80047), lipid panel (80061), hepatic panel (80076), renal function studies, electrolyte panels, glucose, hemoglobin A1c (83036), thyroid function testing (TSH 84443, T3 84480, T4 84436), cardiac markers (troponin I 84484, BNP 83880), iron studies, vitamin D (82306), B12 (82607), arterial blood gases, lactate, and ammonia levels.
Panel optimization is critical here — billing all components individually when fewer than the full CMP or BMP were ordered triggers MUE denials.
Complete blood count with differential (CBC 85025), reticulocyte count (85045), erythrocyte sedimentation rate (85651), peripheral blood smear (85007), prothrombin time PT/INR (85610), partial thromboplastin time PTT (85730), D-dimer (85379), fibrinogen (85384), factor assays, platelet function testing, and bone marrow aspirate analysis.
Automated versus manual methodology distinction is a frequent denial trigger — CBC with auto differential (85025) versus CBC with manual differential (85007) are not interchangeable.
Routine urinalysis with microscopy (81001), automated UA without microscopy (81003), urine drug screening presumptive (80305–80307), serum and urine pregnancy testing (84702, 81025), cerebrospinal fluid analysis, pleural and synovial fluid testing, fecal occult blood (82270), and semen analysis.
The automated strip urinalysis code (81003) versus manual urinalysis codes (81000, 81002) difference is one of the most commonly miscoded tests in physician office labs.
Hormone panels (FSH 83001, LH 83002, estradiol 82670, testosterone 84403), tumor markers (PSA 84153, CEA 82378, CA-125 86304, CA 19-9 86301), cardiac biomarkers (troponin 84484, BNP 83880), autoimmune markers (ANA 86038, RF 86431, anti-CCP 86200), vitamin D (82306), ferritin (82728), transferrin (84466), and infectious disease antibodies.
Quantitative versus qualitative methodology affects both CPT code selection and reimbursement rate — confirmatory testing codes differ from screening test codes.
Bacterial culture and sensitivity — blood (87040), urine (87086), wound, and respiratory; fungal cultures, mycobacterial AFB smear and culture, sexually transmitted infection panels, respiratory pathogen panels (influenza 87804, RSV 87420, COVID-19 87635), H. pylori stool antigen (87338), and ova and parasite examination.
Rapid antigen testing, NAAT, and culture codes are not interchangeable — each reflects a specific methodology with distinct coverage criteria under most commercial and Medicare policies.
Anticonvulsants (phenytoin 80185, valproic acid 80164, carbamazepine 80156), immunosuppressants (tacrolimus 80197, cyclosporine 80158), antibiotics (vancomycin 80202, gentamicin 80170), lithium (80178), digoxin (80162), and methotrexate monitoring.
Medicare LCDs restrict TDM tests to specific diagnosis codes — submitting TDM claims without validated ICD-10 indication linkage is a leading cause of Medicare denials in this category.
ABO and Rh blood typing (86900, 86901), antibody screening (86850), antibody identification (86870), crossmatch testing — electronic and serologic (86920, 86922), direct and indirect antiglobulin testing (86880, 86885), prenatal blood bank panels, cord blood testing, and compatibility testing for irradiated and CMV-negative blood components.
Blood bank billing requires clear documentation of each component tested — bundling of individually reportable tests must be carefully managed to avoid MUE edits.
Cervical cytology Pap smear — liquid-based (88142) and conventional (88150), non-gynecologic cytology (88104–88108), fine needle aspiration cytology (88172–88177), immunohistochemistry staining (88342–88344), surgical pathology specimen coding (88302–88309), and intraoperative consultation frozen section billing (88329–88332).
TC/PC modifier application for pathology services is frequently miscoded — the technical component and professional component must be billed correctly based on whether the lab employs its own pathologist.
TransLabs’ specialized RCM services are built exclusively for labs, addressing the unique challenges that generalist billers miss. We provide end-to-end revenue cycle solutions designed specifically to turn laboratory complexity into profitability.
Complete payer enrollment, CLIA certification management, and network participation setup across all insurance carriers. TransLabs manages every credentialing detail so that your laboratory gets paid in-network from day one without any administrative delays.
Real-time insurance verification, benefits investigation, and prior auth completed before specimen processing begins. Confirming coverage upfront eliminates preventable denials and protects your lab from unexpected reimbursement failures.
Patient registration, appointment coordination, insurance verification, and customer service excellence managed by experienced laboratory billing professionals. A well-run front office reduces downstream billing errors and creates a better experience.
TransLabs provides expert RCM services to clinical laboratories in all 50 states, delivering the same exceptional results whether you’re a community hospital lab or a large reference facility. We bring specialized lab billing expertise to facilities nationwide, combining remote efficiency with hands-on partnership.
Each of Medicare's 12 Administrative Contractors maintains its own LCD policies specifying which ICD-10 diagnosis codes support coverage for specific clinical lab tests. These policies differ by MAC, change without notice, and apply to thousands of test-diagnosis combinations. TransLabs maintains live LCD databases for every MAC and validates diagnosis code linkage on every Medicare claim before submission; not just the most common tests.
Medicare restricts how often certain tests can be covered for the same beneficiary within a defined period. HbA1c, lipid panels, PSA, TSH, and many other high-volume tests carry specific frequency limits that vary by MAC. TransLabs monitors each patient's claim history and alerts ordering providers before frequency limits are reached; preventing the automatic denials that are impossible to appeal after the fact.
When a Medicare beneficiary requests a test that may not meet medical necessity criteria under the applicable LCD, a valid ABN must be issued before the test is performed. Retroactive ABNs are not valid, and billing without a valid ABN when coverage is uncertain exposes the lab to recoupment liability. TransLabs implements ABN workflows into your front-end registration process so the documentation is always in place.
The CLFS sets Medicare payment rates for all lab tests and updates annually on January 1. TransLabs monitors CLFS changes, updates billing tables immediately at each rate change, and identifies when a payer is paying below CLFS rates, allowing proactive underpayment recovery before claim filing deadlines pass.
Labs meeting the applicable laboratory definition under the Protecting Access to Medicare Act (PAMA) carry mandatory private payer data reporting obligations during designated data collection periods. Non-compliance carries civil monetary penalties. TransLabs tracks your lab's PAMA obligations throughout the year and ensures reporting requirements are met accurately and on time.
The Office of Inspector General publishes an annual Work Plan identifying billing areas under active audit scrutiny. Clinical laboratory billing appears on the OIG Work Plan regularly, with tumor markers, genetic testing, and toxicology receiving particular attention in recent cycles. TransLabs builds compliance protocols specifically around current OIG focus areas to reduce audit exposure before it becomes a problem.
Most billing companies treat physicians, hospitals, and labs the same. They’re not. Lab billing has its own CPT codes, compliance rules, LIS ecosystem, and payer dynamics. TransLabs was built exclusively for lab billing; every coder, account manager, and appeal writer works only in labs.
Schedule a call with our clinical lab billing specialist. We’ll review your panel optimization, reflex testing denials, LCD compliance, and A/R days
Dedicated billing specialist assigned to your lab
Complimentary 12 month claims audit across Medicare, Medicaid, and commercial payers
Uncover your top 3 revenue leaks (denials, underpayments, coding gaps)
Custom strategy tailored to your specialty and LIS/billing software
Live in 24 hours with no contracts and no upfront fees
Pay only a percentage of what we collect for you
Lab billing covers diagnostic testing claims, using CPT codes 80000–89999 instead of E&M codes. Labs bill under the Clinical Laboratory Fee Schedule, not the Physician Fee Schedule, and face MAC-specific LCDs, PAMA reporting, and frequency limits — plus higher claim volume from multiple referring providers.
It decides whether to bill tests as a panel code (e.g., CMP, BMP, lipid panel) or individual components, based on what was performed and payer rules. Errors trigger MUE denials or compliance violations. TransLabs automates this logic on every claim.